Norbert Riedel

Norbert Riedel, Ph.D., is president and chief executive officer of Aptinyx Inc., a biopharmaceutical company, where he also serves as a member of the board of directors. Dr. Riedel was formerly president and chief executive officer of Naurex Inc., the predecessor company acquired by Allergan and from which Aptinyx and its technology were spun out. Prior to Naurex, he served in various roles at Baxter International Inc., most recently as corporate vice president and chief science and innovation officer. Previously, he was head of worldwide biotechnology and held a number of scientific management positions at Hoechst-Marion Roussel (now Sanofi).